Ignite Creation Date:
2025-12-25 @ 5:00 AM
Ignite Modification Date:
2026-05-10 @ 3:22 PM
Study NCT ID:
NCT04441918
Status:
UNKNOWN
Last Update Posted:
2020-06-22
First Post:
2020-06-06
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Tolerability,Safety,Pharmacokinetic Profile and Immunogenicity of a Recombinant Humanized Anti-SARS-CoV-2 Monoclonal Antibody (JS016) for Injection in Chinese Health Subjects
Sponsor:
Shanghai Junshi Bioscience Co., Ltd.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | COVID-19; and High Infection Risk of SARS-CoV-2 | View |
Keywords: